3,917
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Antiviral activity of curcumin-nanoemulsion associated with photodynamic therapy in vulvar cell lines transducing different variants of HPV-16

, , , , , , , , , , , , , , & show all
Pages 515-524 | Received 28 May 2019, Accepted 28 Dec 2019, Published online: 12 Feb 2020

References

  • Preti M, Scurry J, Marchitelli CE, et al. Vulvar intraepithelial neoplasia, best practice and research. Clin Obstet Gynaecol. 2014;28:1051–1062.
  • Vuyst HD, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626–1636.
  • de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324(1):17–27.
  • Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996;69(5):364–368.
  • Grodzki M, Besson G, Clavel C, et al. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant, Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research. Am Soc Prevent Oncol. 2006;15:820–822.
  • Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J General Virol. 2000;81(12):2959–2968.
  • Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6):441–448.
  • Nelson EL, Stockdale CK. Vulvar and vaginal HPV disease. Obstet Gyn Clin N Am. 2013;40(2):359–376.
  • Lacey CJ. Therapy for genital human papillomavirus-related disease. J Clin Virol. 2005;32(1):82–90. Suppl
  • Singh M, Tyagi S, Bhui K, et al. Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest New Drugs. 2010;28(3):216–224.
  • Garcia-Zepeda SP, Garcia-Villa E, Diaz-Chavez J, et al. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur J Cancer Prev. 2013;22:577–584.
  • Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharmaceutics. 2007;4(6):807–818.
  • Ma Z, Haddadi A, Molavi O, et al. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res. 2008;86:300–310.
  • Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharmaceutics. 2009;6(3):928–939.
  • Shaikh J, Ankola DD, Beniwal V, et al. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37(3–4):223–230.
  • Gupta A, Eral HB, Hatton TA, et al. Nanoemulsions: formation, properties and applications. Soft Matter. 2016;12(11):2826–2841.
  • Primo FL, de Paula LB, de Siqueira-Moura MP, et al. Photobiostimulation on wound healing treatment by ClAlPc-nanoemulsion from a multiple-wavelength portable light source on a 3D-human stem cell dermal equivalent. CMC. 2012;19(30):5157–5163.
  • Franchi LP, Amantino CF, Melo MT, et al. In vitro effects of photodynamic therapy induced by chloroaluminum phthalocyanine nanoemulsion. Photodiagnosis Photodynamic Ther. 2016;16:100–105.
  • de Jesus PD, Saeki SI, Tedesco AC. An ex vivo study of photobiostimulation in the treatment of skin pathologies. J Biophoton. 2016;9(11–12):1189–1198.
  • Pellosi DS, De Jesus P, Tedesco AC. Spotlight on the delivery of photosensitizers: different approaches for photodynamic-based therapies. Expert Opin Drug Del. 2017;14(12):1395–1406.
  • Buggiani G, Troiano M, Rossi R, et al. Photodynamic therapy: off-label and alternative use in dermatological practice. Photodiagnosis Photodyn Ther. 2008;5(2):134–138.
  • MacCormack MA. Photodynamic therapy in dermatology: an update on applications and outcomes. Semin Cutan Med Surg. 2008;27(1):52–62.
  • Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250–281.
  • Lieder A, Khan MK, Lippert BM. Photodynamic therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev. 2014;5(6):CD009810.
  • Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 2000;38(1):357–361.
  • Bernard HU, Chan SY, Manos MN, et al. Identification and assessment of known and novel human papillomaviruses by Polymerase Chain Reaction amplification, restriction fragment lenght polymorphisms, nucleotide sequence and phylogenetic algorithms. J. Infect. Dis. 1994;170:1077–1085.
  • Hall TA. Bioedit: A User-Friendly Biological Sequence Alignment Editor and Analysis Program for Windows 95/98/NT. Nucleic Acids Symposium Series. 1999;41:95–98.
  • Boccardo E, Manzini Baldi CV, Carvalho AF, et al. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha. Carcinogenesis. 2010;31(3):521–531.
  • Calmon MF, Sichero L, Boccardo E, et al. HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines. Virology. 2016;496:35–41.
  • Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45–45.
  • Boccardo E, Noya F, Broker TR, et al. HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology. 2004;328(2):233–243.
  • Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19.
  • Insinga RP, Liaw KL, Johnson LG, et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States, Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the. Am Soc Prevent Oncol. 2008;17:1611–1622.
  • Wan MT, Lin JY. Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol. 2014;7:145–163.
  • van de Nieuwenhof HP, Massuger LF, van der Avoort IA, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45(5):851–856.
  • de Sanjose S, Alemany L, Ordi J, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49:3450–3461.
  • Smith JS, Backes DM, Hoots BE, Kurman RJ, et al. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol. 2009;113:8.
  • Rapose A. Human papillomavirus and genital cancer. Indian J Dermatol Venereol Leprol. 2009;75(3):236–243.
  • Deda DK, Budu A, Cruz LN, et al. Strategies for development of antimalarials based on encapsulated porphyrin derivatives. Mini Rev Med Chem. 2015;14(13):1055–1071.
  • Banerjee S, Prasad P, Hussain A, et al. Remarkable photocytotoxicity of curcumin in HeLa cells in visible light and arresting its degradation on oxovanadium(IV) complex formation. Chem Commun. 2012;48(62):7702–7704.
  • Araujo NC, Fontana CR, Gerbi ME, et al. Overall-mouth disinfection by photodynamic therapy using curcumin. Photomed Laser Sur. 2012;30:96–101.
  • Feng YJ, Blackburn DC, Liang D, et al. Phylogenomics reveals rapid, simultaneous diversification of three major clades of Gondwanan frogs at the Cretaceous-Paleogene boundary. Proc Natl Acad Sci USA. 2017;114(29):E5864–E5870.
  • Jiang B, Li C, Dag O, et al. Mesoporous metallic rhodium nanoparticles. Nat Commun. 2017;8(1):15581.
  • Yilmaz E, Borchert HH. Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Euro J Pharm Biopharm. 2005;60(1):91–98.
  • Park HJ. Kong M. Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr Polym. 2011;83:8.
  • Rachmawati H, Budiputra DK, Mauludin R. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm. 2015;41(4):560–566.
  • Lv Y, Yang B, Jiang T, et al. Folate-conjugated amphiphilic block copolymers for targeted and efficient delivery of doxorubicin. Colloids Surf B Biointerfaces. 2014;115:253–259.
  • Patra S, Roy E, Madhuri R, et al. The next generation cell-penetrating peptide and carbon dot conjugated nano-liposome for transdermal delivery of curcumin. Biomater Sci. 2016;4(3):418–429.
  • Kumari P, Swami MO, Nadipalli SK, et al. Curcumin delivery by Poly(Lactide)-Based Co-Polymeric micelles: an in vitro anticancer study. Pharm Res. 2016;33(4):826–841.
  • Ahn JC, Kang JW, Shin JI, et al. Combination treatment with photodynamic therapy and curcumin induces mitochondria-dependent apoptosis in AMC-HN3 cells. Int J Oncol. 2012;41(6):2184–2190.
  • Yan D, Geusz ME, Jamasbi RJ. Properties of lewis lung carcinoma cells surviving curcumin toxicity. J Cancer. 2012;3:32–41.
  • Bush JA, Cheung KJ, Jr., Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res. 2001;271(2):305–314.
  • Maher DM, Bell MC, O’Donnell EA, et al. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Mol Carcinog. 2011;50(1):47–57.